Acquisition of approximately 71% stake in Kokomodo Ltd. Acquisition uniquely combines Pluri's mass-scale cell production expertise with Kokomodo Ltd.'s ability to craft real, controlled, climate-resilient cacao using cellular agriculture technology HAIFA, Israel, April 28, 2025 ( GLOBE NEWSWIRE ...

Latest granted patents reinforce Pluri's position as a leader in Mucosal-Associated Invariant T ( "MAIT" ) cell-based cell therapies for solid cancers Pluri's MAIT platform enables commercial scale production of powerful immune cells as a potential first-in-class, ready to use, ...

Strategic initiative to address Ukraine's urgent need for radiation countermeasures Hemafund's infrastructure ensures secure storage and rapid deployment of emergency treatments Collaboration may potentially generate over $100 million in value for both parties

Private placement of $6.5 million with a global investor and entrepreneur, Mr. Alejandro Weinstein, who will join Pluri's Board of Directors Pluri to purchase approximately 71% of Kokomodo Ltd.'s shares, a leading AgTech company focused on the production of cacao, subject to shareholder approval

HAIFA, Israel, Jan. 23, 2025 ( GLOBE NEWSWIRE ) -- Pluri Inc. ( Nasdaq: PLUR ) ( TASE:PLUR ) ( "Pluri" or the "Company" ) , a leading biotechnology company leveraging its proprietary platform for cell-based solutions to create a collaborative network of ventures, today announced a $6.5 million ...

HAIFA, Israel, Nov. 25, 2024 ( GLOBE NEWSWIRE ) -- Pluri Inc.

The Israel Innovation Authority will fund Pluri and BIRAD's collaboration to advance MAIT Cell Therapy, led by Professor Cyrille Cohen, Head of the laboratory of tumor immunology and immunotherapy at Bar-Ilan University

PluriCDMO™, the Company's contract development and manufacturing organization, recognized as a leading manufacturing partner offering scalability and mass scale production to a growing number of innovative life science companies PluriCDMO™, the Company's contract development and manufacturing ...

Market regulator Sebi on Friday disposed of its investigation against Unitech's erstwhile promoters Sanjay Chandra and Ajay Chandra in a case pertaining to the alleged routing of funds to the Indian securities market using overseas bank accounts as it found no evidence.